Ad is loading...
FSPSX
Price
$49.16
Change
-$0.27 (-0.55%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

FSPSX vs VTSNX

Header iconFSPSX vs VTSNX Comparison
Open Charts FSPSX vs VTSNXBanner chart's image
Fidelity International Index
Price$49.16
Change-$0.27 (-0.55%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
FSPSX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSPSX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPSX is a Sell and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. FSPSX (52.9B). VTSNX pays higher dividends than FSPSX: VTSNX (3.29) vs FSPSX (2.64). FSPSX was incepted earlier than VTSNX: FSPSX (13 years) vs VTSNX (14 years). FSPSX (4.00) and VTSNX (4.00) have comparable annual turnover. FSPSX has a lower initial minimum investment than VTSNX: FSPSX (0) vs VTSNX (5000000). FSPSX annual gain was more profitable for investors over the last year : 12.34 vs. VTSNX (10.92). FSPSX return over 5 years is better than : 27.58 vs. VTSNX (15.91).
FSPSXVTSNXFSPSX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years14 years-
Gain YTD4.1994.53593%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets52.9B442B12%
Annual Yield % from dividends2.643.2980%
Returns for 1 year12.3410.92113%
Returns for 3 years4.96-5.86-85%
Returns for 5 years27.5815.91173%
Returns for 10 years47.2329.81158%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals